Efficacy of unani drug Itrifal-e-Sagheer in the treatment of obesity.
Phase 2
Completed
- Conditions
- Health Condition 1: null- Dyslipidaemia
- Registration Number
- CTRI/2017/09/009783
- Lead Sponsor
- Sazid Alam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Diagnosed patients of dyslipidaemia
2.Patients of either gender in age group of 20-60 years
Exclusion Criteria
1.Other systemic disorders like DM, liver failure, kidney failure, etc.
2.Pregnant and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in subjective parametersTimepoint: 45 DAYS
- Secondary Outcome Measures
Name Time Method Serum Cholesterol <br/ ><br>Serum triglyceride <br/ ><br>LDL <br/ ><br>HDL <br/ ><br>Timepoint: 45days